Login / Signup

Outcomes of IncobotulinumtoxinA Injection on Myalgia and Arthralgia in Patients Undergoing Temporomandibular Joint Arthroscopy: A Randomized Controlled Trial.

David Serrano Faustino ÂngeloDavid SanzFrancesco MaffìaHenrique José Cardoso
Published in: Toxins (2023)
In patients submitted to TMJ arthroscopy, statistically significant long-term differences were observed between the placebo and inco-BoNT/A groups.
Keyphrases
  • patients undergoing
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors
  • clinical trial
  • patient reported outcomes
  • adipose tissue
  • weight loss
  • placebo controlled